Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Transfer Devices Assessed for Malaria Test

By LabMedica International staff writers
Posted on 16 Feb 2011
A comparison has been made of different devices for transferring blood to the rapid diagnostic test (RDT) for malaria in three developing countries.

The five blood transfer devices evaluated were the loop and inverted cup, made of hard plastic; a straw-pipette and calibrated pipette, made of soft plastic, and a glass capillary tube.

A study was conducted between August and November 2009 among 227 health workers in Nigeria, the Philippines, and Uganda, under the auspices of the Foundation for Innovative New Diagnostics, (FIND; Geneva, Switzerland). The participants were recruited from the staff of frontline health centers and community-based malaria programs. The devices were evaluated for accuracy, safety, and ease of use. The participating health workers used each device to transfer blood from a simulated finger prick site to filter paper. Blood volume transferred was calculated from the area of blood spots deposited on filter paper.

The overall mean volumes transferred by devices differed significantly from the target volume of 5 μL which is the minimum amount recommended for the most RDTs. The new inverted cup device transferred a mean of 4.6 μL, which most closely approximated the target volume. The glass capillary was excluded from volume analysis, as the estimation method used is not compatible with this device. The calibrated pipette accounted for the largest proportion of blood exposures to 10% of the health worker. Blood exposures for the other four devices ranged from 2% to 6%. According to 91% of the health workers, the inverted cup was considered easiest to use in blood collection, while the straw-pipette and calibrated pipette were rated the most difficult to use.

Rapid diagnostic tests are becoming the standard method of detection of malaria in poor resource settings. The blood transfer device is an essential part of the kit because the sensitivity of the tests is compromised when an inadequate volume is transferred to the RDT cassette, especially when parasite density falls below 200 parasite/μL. The findings of this study have relevance for any point-of-care diagnostics that require blood sampling. The variability in device performance demonstrated the need to devote attention to this issue when implementing RDT-based diagnostic programs. The study was published online on February 8, 2011, in the Malaria Journal.

Related Links:

Foundation for Innovative New Diagnostics






Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Troponin I Test
Quidel Triage Troponin I Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.